Merck & Co., Inc.
MRKLast close · Oct 16, 2026145.97+0.78 (+0.53%)
Market cap$360.1B
17 firms' latest targets, last 90 days: median $170.00 ($105.00–$180.00), 16% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-10-12 | RBC Capital | $145.00 | ▼ 3% | -1% |
| 2026-10-08 | Cantor Fitzgerald | $145.00 | ▲ 25% | -1% |
| 2026-09-29 | Scotiabank | $180.00 | ▲ 16% | +23% |
| 2026-09-11 | Berenberg Bank | $137.00 | — | -6% |
| 2026-09-10 | HSBC | $172.00 | ▲ 15% | +18% |
| 2026-09-09 | Leerink Partners | $161.00 | — | +10% |
| 2026-09-08 | Guggenheim | $170.00 | ▲ 16% | +16% |
| 2026-09-04 | Wells Fargo | $170.00 | ▲ 13% | +16% |
| 2026-08-25 | Argus Research | $170.00 | ▲ 17% | +16% |
| 2026-08-25 | Wolfe Research | $180.00 | ▲ 33% | +23% |
| 2026-08-21 | Goldman Sachs | $160.00 | ▲ 20% | +10% |
| 2026-08-20 | BMO Capital | $170.00 | ▲ 20% | +16% |
| 2026-08-20 | UBS | $175.00 | ▲ 17% | +20% |
| 2026-08-19 | Morgan Stanley | $179.00 | ▲ 54% | +23% |
| 2026-08-12 | Daiwa | $143.00 | — | -2% |
| 2026-07-29 | Barclays | $150.00 | — | +3% |
| 2026-07-27 | Bernstein | $105.00 | ▲ 5% | -28% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2023reported | $60.1B | +1% | $0.14 | -98% | est. $60.0B+0% | est. $1.38 | 15 |
| 2024reported | $64.2B | +7% | $6.74 | +4714% | est. $64.0B+0% | est. $7.53 | 15 |
| 2025reported | $65.0B | +1% | $7.28 | +8% | est. $64.9B+0% | est. $8.93 | 15 |
| 2026 | $67.1B | +3% | $2.66 | -70% | $66.8B–$67.2B | $2.50–$2.76 | 17 |
| 2027 | $69.8B | +4% | $9.28 | +249% | $68.8B–$71.7B | $8.55–$10.01 | 17 |
| 2028 | $73.8B | +6% | $10.22 | +10% | $70.1B–$79.7B | $8.02–$12.21 | 20 |
| 2029 | $74.5B | +1% | $9.98 | -2% | $72.9B–$76.6B | $9.69–$10.35 | 10 |
| 2030 | $75.1B | +1% | $9.90 | -1% | $73.4B–$77.2B | $9.62–$10.27 | 10 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.